Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype
Artemeva, N.V., Safarova, M.S., Ezhov, M.V., Afanasieva, O.I., Dmitrieva, O.A., Pokrovsky, S.N.Volume:
18
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/j.atherosclerosissup.2015.02.008
Date:
May, 2015
File:
PDF, 360 KB
english, 2015